Black Diamond Therapeutics, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001701541-25-000039
- Form type
- 10-Q
- CIK
- 0001701541
- Primary document
- https://www.sec.gov/Archives/edgar/data/1701541/000170154125000039/bdtx-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Black Diamond Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $30.1M | - | - |
| Net Income | $37.5M | - | - |
| Eps Basic | 0.66 | - | - |
| Eps Diluted | 0.65 | - | - |
| Cash And Equivalents | $30.9M | - | - |
| Total Assets | $157.7M | - | - |
| Total Liabilities | $31.6M | - | - |
| Shareholders Equity | $126.2M | - | - |
| Operating Cash Flow | $36.4M | - | - |